Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Ravindra Ganesh and Brian Kennedy.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.302
         
        
        
     
 
    
        
        - 
            Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
            
            
                Score: 0.244
            
         
        
        - 
            A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
            
            
                Score: 0.058